835 Heterologous prime boost viral vector vaccination provides protection against intracranial syngeneic murine glioblastoma
Main Authors: | Mark Gilbert, Wei Zhang, Hideho Okada, Masaki Terabe, Gary Kohanbash, Hua Song, Dionne Davis, James McAuliffe, Laurine Noblecourt, Emily E Steffke, Taijun Hana, Laila Latifi, Vinnycius Pereira Almeida, Amanda Wicki, Morgan Coombs, Nargis Malik, Meili Zhang, Nicole Briceno, Carol Leung, Benoit Van den Eynde |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
by: McAuliffe, J, et al.
Published: (2021) -
Fabricate an 8.35-GHz frequency synthesizer
by: Attaran, A., et al.
Published: (2011) -
Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse models
by: Apeng Chen, et al.
Published: (2023-03-01) -
P835: GENETIC BACKGROUND AND CLINICAL CHARACTERISTICS OF CONGENITAL NEUTROPENIAS IN ISRAEL
by: O. Steinberg-Shemer, et al.
Published: (2022-06-01) -
Glioblastoma vaccines: past, present, and opportunities
by: Zujian Xiong, et al.
Published: (2024-02-01)